The largest database of trusted experimental protocols

9 protocols using hx531

1

Cloning and Luciferase Assay for VDR and RXR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse vdr, rxrα, and rxrβ sequences were cloned using the pcDNA6/V5-HisA vector, and mouse genomic DNA sequences for app, bace1, psen1, and the human genomic bace1 sequences were cloned using the firefly luciferase reporter vector pGL4.14 (Promega, USA) or pGL3 with pfu DNA polymerase (Solgent, South Korea). Site-specific mutagenesis and deletion mutants were performed with a QuikChange Site-Directed Mutagenesis Kit (Stratagene, USA) with the gene-specific primers listed in Appendix B Table A2. All sequences were verified. HEK293 cells in 12-well plates were transfected with FuGENE (1–4 μL per 0.5 μg DNA; Roche), and a total of 1.0 μg of DNA (1.0 μg of pGL4.14/pGL3 luciferase reporter, 0.5–1.0 μg of wild-type or mutated pcDNA6/V5-HisA-VDR, pcDNA6/V5-HisA-RXRα, or pcDNA6/V5-HisA-RXRβ, 0.1 μg of pRL-TK-expressing control Renilla luciferase, and the remaining pcDNA6/V5-HisA). HX531 (SML2170, Sigma-Aldrich), a synthetic RXR antagonist, was dissolved in DMSO and added at 2.5, 5.5, and 10.0 μM. Cells were lysed 24–36 h after transfection, and the lysates were rocked at room temperature for 15 min and centrifuged at 8000 rpm for 10 min. A 30 μL volume of supernatant was subjected to luciferase assays with a Centro XS3 LB luminometer (Berhold, Germany). The ratios (firefly/Renilla) of relative luciferase activity were determined.
+ Open protocol
+ Expand
2

Diverse Pharmacological Modulators of Nuclear Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
AM580 (Tocris, #0760, Germany), ER50891 (Tocris, #3823, Germany), CD2314 (Tocris, #3824, Germany), LE135 (Tocris, #2021, Germany), CD437 (Sigma, #C5865, USA), MM11253 (Tocris, #3822, Germany), ATRA (Sigma, #R2625, USA), BMS493 (Sigma, #B6688, USA), GW7647 (Tocris, #1677, Germany), GW6471 (Tocris, #4618, Germany), GW0742 (Tocris, #2229, Germany), GSK3787 (Tocris, #3961, Germany), Troglitazone (Sigma, #T2573, USA), T0070907 (Sigma, #T8703, USA), T0901317 (Sigma, #T2320, USA), SR9238 (Tocris, #5854, Germany), GC1 (Tocris, #4554, Germany), Calcifediol (Tocris, #4036, Germany), SR9011 (Sigma, #SML2067, USA), SR8278 (Tocris, #4463, Germany), CD3254 (Tocris, #3302, Germany), HX531 (Sigma, #SML2170, USA), Testosterone (Aladdin, #T102169, China), Nilutamide (Sigma, #N8534, USA), XCT790 (Sigma, #X4753, USA), Dexamethasone (Sigma, #D4902, USA), Mifepristone (Sigma, #M8046, USA), Corticosterone (Aladdin, #C104537, China), Eplerenone (Sigma, #E6657, USA), Doxorubicin (Solarbio, #D8740, China), Blasticidin (Beyotime, #ST018, China), Puromycin (Beyotime, # ST551, China).
+ Open protocol
+ Expand
3

Macrophage Polarization Modulated by NR Agonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 monocytes were cultured in RPMI supplemented with 10% FBS, 0.05 mM 2-mercaptoethanol and 1% antibiotic–antimycotic (100×), and differentiated into macrophages with 100 nM phorbol 12-myristate 13-acetate (PMA) for 72 hours, and then recovered in fresh media for 48 hours. To perform the functional assays, THP-1-derived macrophages were pre-treated with the respective NR agonists/antagonists for 15 min, and then polarized to M2 macrophages with 25 ng/ml IL4 and 25 ng/ml IL13 for 48 hours to promote IL10 production. The supernatants were collected and the amount of IL10 in the supernatants were measured using the Human IL10 ELISA MAX (Biolegend) kit according to the manufacturer's protocol. NR agonists/antagonists: NR1I2 agonist SR12813 (Tocris), NR1I2 antagonist SPA70 (Axon), RXR agonist Bexarotene (Tocris), RXR antagonist HX531 (Sigma Aldrich), and VDR agonist Ercalcitriol (Tocris). Each experimental condition was tested in quadruplicate and the experiment was performed twice.
+ Open protocol
+ Expand
4

Theca Cell Viability Assay with Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, all chemicals were dissolved in DMSO at 0.05% (v/v). Control groups were exposed to DMSO at 0.05% (v/v). Cell viability was evaluated using an MTT assay as described previously (Pu et al., 2019 (link)). Theca cells were seeded, cultured in growth medium, and exposed to TPT chloride (Cat# 45492, Sigma, St. Louis, MO, USA; concentrations: 0, 0.1, 1, 10, 20, 50, 100 and 1,000 ng/ml) and/or an LXR antagonist (GSK2033; Cat# SML1617, >98%, Sigma, St. Louis, MO, USA; concentrations: 0, 0.1, 0.5, 1, 2 and 5 μM) and RXR antagonist (HX531; Cat# SML2170, >98%, Sigma, St. Louis, MO, USA; concentrations: 0, 0.1, 0.5, 1, 2 and 5 μM) and PPARγ antagonist (T0070907; Cat# T8703, >98%, Sigma, St. Louis, MO, USA; concentrations: 0, 0.1, 0.5, 1, 2.5, 5, and 10 μM) in the growth medium for 72 h. Cells were then incubated with MTT (50 μg/ml) for 4 h in a phenol red free DMEM medium. After replacing with DMSO, cells were vortexed for 10 min, and cell viability measured by absorbance quantification at 570 nm with a microplate reader (SpectraMax M5e, Molecular Devices LLC, Sunnyvale, CA, USA). Chemical exposure was begun right after serum starvation for 48 h on pre-luteinized and 72 h on cells during their luteinization.
+ Open protocol
+ Expand
5

Organoid Transcriptional Modulation by Retinoid Analogs

Check if the same lab product or an alternative is used in the 5 most similar protocols
24 hours after splitting, organoids were treated with either ENR – Vitamin A containing 0.1% final volume DMSO, ENR + Vitamin A containing 0.1% final volume DMSO 5μM all-trans-Retinoic acid (ATRA, Cayman Chemical), 10μM 9- cis-Retinoic acid (9-cisRA, Cayman Chemical), 1μM AGN193109 (Sigma Aldrich), 1μM NRX194204 (Axon Medchem), 1μM HX531 (Sigma Aldrich) or 10 μM LG100268 (Sigma Aldrich). Drugs were stored under reduced light conditions and exposure to light was minimized. Media containing compounds was refreshed after 24h. Total treatment time was 48h for all drugs. All drugs were dissolved in DMSO and added to the culture medium at working concentration in 0.1% final volume DMSO. After treatment, organoids were harvested using Organoid Harvesting Solution (Cultrex, R&D Systems) and pelleted. Pellets were snap frozen and stored at −80 C for RNA-sequencing, or cryopreserved to maintain native chromatin context for ATAC-sequencing.
+ Open protocol
+ Expand
6

Lipid Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
M-CSF and GM-CSF were purchased from Cell Signaling Technology (Danvers, MA). All FAs were from Nu-Chek Prep. PA (5 mM), SA (5 mM), OA (5 mM), LA (5 mM), eicosapentaenoic acid (EPA, 5mM) and α-linolenic acid (ALA) (2mM) were prepared with 2 mM of endotoxin-free BSA in PBS (Cat#: BP9705-100, FISHER Scientific), sonicated until dissolved, and filtered through 0.22mm sterile filter as we previously described (14 ,15 (link)). The specific reactive oxygen species (ROS) inhibitors 4-amino-2,4-pyrrolidine-dicarboxylic acid (APDC) and butylated hydroxyanisole (BHA), PPARδ agonist GW0742 and antagonist GSK0660, PPARγ agonist Rosiglitazone and antagonist GW9662, RXR agonist LG100268 and antagonist HX531 were purchased from Sigma-Aldrich. RAR agonist BM753 and antagonist BMS195640 were purchased from TOCRIS. Necrosis inhibitor IM54 and apoptosis inhibitor z-VAD-FMK were purchased from Enzo Life Sciences. TLR4 inhibitor Eritoran, STAT3 inhibitor NSC74859, NFҡB inhibitor CAPE, IKK inhibitor BMS-345541, Cer synthesis inhibitor FB1 (fumonisin B1) and SPT (serine palmitoyltransferase) were purchased from Cayman Chemical.
+ Open protocol
+ Expand
7

Screening Compounds for Nuclear Receptor Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dexamethasone, isobutylmethylxanthine, Nile red, Hoechst 33342, HX531, LG100268 (LG), 2,4-di-tert-butylphenol (2,4-DTBP), 2,6-di-tert-butylphenol (2,6-DTBP), 2,4,6-tri-tert-butylphenol (2,4,6-TTBP), 1,3-di-tert-butylbenzene (1,3-DTBB), 1,3,5-tri-tert-butylbenzene (1,3,5-TTBB), LG100268, GW3065, T3, and TTNPB were purchased from Sigma-Aldrich. CD3254 was purchased from Tocris Bioscience. Rosiglitazone (ROSI) was purchased from Cayman Chemical Company. T0070907 was from Enzo Life Sciences. Dimethylsulfoxide (DMSO) was purchased from Thermo Fisher Scientific.
+ Open protocol
+ Expand
8

PPAR Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All usual chemicals, primers, and HX531 were from Sigma (St. Louis, MO, USA). Reagents for cell culture, transfection and quantitative RT-PCR were from Thermo Fisher Scientific (Waltham, MA, USA). RNA extraction NucleoSpin® RNA kit was from Macherey Nagel (Düren, Germany). ECL prime and PVDF membrane were from Amersham GE Healthcare (Buckinghamshire, UK). Primary antibodies against the following proteins were used: GAPDH (Santa Cruz Biotechnology, Inc, Dallas, TX, USA); pAKT, AKT, pERK and ERK (Cell Signaling, Danvers, MA, USA). Secondary antibodies were from Jackson ImmunoResearch (Cambridgeshire, UK). GW9578 was from Cayman Chemical Company (Ann Arbor, MI, USA) and GW0742, TGZ, T007907, GSK3787, MK886 and HX630 were purchased from TOCRIS (Bristol, UK). Cignal Pathway Reporter Assay Kits were from QIAGEN (Frederick, MD, USA). The Dual-Luciferase Reporter Assay System was purchased from Promega (Madison, WI, USA). pcDNA 3.1 (+)-PPARα and pcDNA 3.1 (+)-PPARβ/δ (pig sequence) were purchased from Genscript (Piscataway, NJ, USA). pCMV6-XL4-PPARγ (human sequence) was purchased from Origene (Rockville, MD, USA).
+ Open protocol
+ Expand
9

Modulation of IL10 Production in M2 Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 monocytes were cultured in RPMI supplemented with 10% FBS, 0.05 mM 2mercaptoethanol, and 1% Antibiotic-Antimycotic (100X), and differentiated into macrophages with 100 nM phorbol 12-myristate 13-acetate (PMA) for 72 hours, and then recovered in fresh media for 48 hours. To perform the functional assays, THP-1-derived macrophages were incubated with the respective NR agonists/antagonists for 15 minutes, and then polarized to M2 macrophages with 25 ng/ml IL4 and 25 ng/ml IL13 for 48 hours to promote IL10 production. The supernatants were collected and the amount of IL10 in the supernatants were measured using the Human IL10 ELISA MAX (Biolegend) kit according to the manufacturer's protocol. NR agonists/antagonists: NR1I2 agonist SR12813 (Tocris), NR1I2 antagonist SPA70 (Axon), RXR agonist Bexarotene (Tocris), RXR antagonist HX531 (Sigma Aldrich), and VDR agonist Ercalcitriol (Tocris).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!